Crystalvue Medical Corporation

TPEX:6527 Stock Report

Market Cap: NT$2.2b

Crystalvue Medical Past Earnings Performance

Past criteria checks 3/6

Crystalvue Medical has been growing earnings at an average annual rate of 11.5%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 9.2% per year. Crystalvue Medical's return on equity is 12.7%, and it has net margins of 13.9%.

Key information

11.5%

Earnings growth rate

9.7%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate9.2%
Return on equity12.7%
Net Margin13.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

The Returns On Capital At Crystalvue Medical (GTSM:6527) Don't Inspire Confidence

Apr 05
The Returns On Capital At Crystalvue Medical (GTSM:6527) Don't Inspire Confidence

Has Crystalvue Medical Corporation (GTSM:6527) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Mar 10
Has Crystalvue Medical Corporation (GTSM:6527) Stock's Recent Performance Got Anything to Do With Its Financial Health?

Consider This Before Buying Crystalvue Medical Corporation (GTSM:6527) For The 5.2% Dividend

Feb 10
Consider This Before Buying Crystalvue Medical Corporation (GTSM:6527) For The 5.2% Dividend

Are Crystalvue Medical's (GTSM:6527) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 20
Are Crystalvue Medical's (GTSM:6527) Statutory Earnings A Good Reflection Of Its Earnings Potential?

The Returns At Crystalvue Medical (GTSM:6527) Provide Us With Signs Of What's To Come

Dec 30
The Returns At Crystalvue Medical (GTSM:6527) Provide Us With Signs Of What's To Come

Could The Market Be Wrong About Crystalvue Medical Corporation (GTSM:6527) Given Its Attractive Financial Prospects?

Dec 09
Could The Market Be Wrong About Crystalvue Medical Corporation (GTSM:6527) Given Its Attractive Financial Prospects?

Revenue & Expenses Breakdown

How Crystalvue Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6527 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2483411610539
30 Jun 2482010511245
31 Mar 2481610810745
31 Dec 2382410310445
30 Sep 238661159854
30 Jun 238561289146
31 Mar 238661209248
31 Dec 227951159047
30 Sep 227571088851
30 Jun 22728898150
31 Mar 22682807447
31 Dec 21722777449
30 Sep 21701707445
30 Jun 21675757348
31 Mar 21568646944
31 Dec 20504576641
30 Sep 20489625937
30 Jun 20505616637
31 Mar 20597737740
31 Dec 19661918443
30 Sep 19687949547
30 Jun 19685988844
31 Mar 19657897941
31 Dec 18606707239
30 Sep 18548555935
30 Jun 18507415534
31 Mar 18500375134
31 Dec 17494344634
30 Sep 17487334436
30 Jun 17481324337
31 Mar 17512414538
31 Dec 16542504739
30 Sep 16552584839
30 Jun 16562674939
31 Mar 16513594639
31 Dec 15465514339
30 Sep 15444483940
30 Jun 15423453642
31 Mar 15411443344
31 Dec 14398423146

Quality Earnings: 6527 has high quality earnings.

Growing Profit Margin: 6527's current net profit margins (13.9%) are higher than last year (13.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6527's earnings have grown by 11.5% per year over the past 5 years.

Accelerating Growth: 6527's earnings growth over the past year (0.3%) is below its 5-year average (11.5% per year).

Earnings vs Industry: 6527 earnings growth over the past year (0.3%) did not outperform the Medical Equipment industry 5%.


Return on Equity

High ROE: 6527's Return on Equity (12.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 01:02
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Crystalvue Medical Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu-Ying YangKGI Securities Co. Ltd.
Hsiu Chi LinMasterlink Securities Corp.